Pfizer Inc
PFE
Company Profile
Business description
Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding covid-19-related product sales). While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, and cardiovascular treatment Eliquis. Pfizer sells these products globally, with international sales representing close to 50% of total sales. Within international sales, emerging markets are a major contributor.
Contact
66 Hudson Boulevard East
New YorkNY10001-2192
USAT: +1 212 733-2323
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - General
Fiscal Year End
31 December 2025
Employees
88,000
Stocks News & Analysis
stocks
Unconventional wisdom: A controversial income pick
Rigid definitions of income and growth shares may be holding investors back.
stocks
How to avoid dividend disaster
Thinking about common reasons a company might stop paying a dividend can help income investors avoid disappointment.
stocks
Why ASX miners will handily beat banks in the long-term
After a stellar run for banks, investors are wondering whether they can continue their outperformance or if a rotation into miners is imminent. There’s a good case that a switch is coming, and it may last decades, not just years.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 8,780.30 | 4.80 | -0.05% |
CAC 40 | 7,973.03 | 34.59 | -0.43% |
DAX 40 | 21,787.00 | 115.42 | -0.53% |
Dow JONES (US) | 44,303.40 | 444.23 | -0.99% |
FTSE 100 | 8,700.53 | 26.75 | -0.31% |
HKSE | 21,133.54 | 241.92 | 1.16% |
NASDAQ | 19,523.40 | 268.59 | -1.36% |
Nikkei 225 | 38,787.02 | 279.51 | -0.72% |
NZX 50 Index | 12,902.19 | 57.60 | 0.45% |
S&P 500 | 6,025.99 | 57.58 | -0.95% |
S&P/ASX 200 | 8,511.40 | 9.30 | -0.11% |
SSE Composite Index | 3,303.67 | 33.01 | 1.01% |